The $493K director buy is too small to be a standalone signal. Monitor for larger insider purchases, especially from C-suite executives, or a catalyst event (e.g., FDA decision, pipeline update) that could justify a more material position. The strong analyst consensus already prices in bullish expectations.
ASND drugs
ASND drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 19 $259.62entry
- T+1 · 3mo ago −1.85%α −1.01% · $254.81
- T+5 · 3mo ago −3.61%α −3.22% · $250.25
- T+20 · 2mo ago −7.93%α −5.98% · $239.04
- T+60 · 5d ago +2.87%α +4.42% · $267.07
Price Chart
How similar events traded
Executive Summary
Director Jean Jacques Bienaime purchased $493K of ASND stock in two open-market transactions on August 14, 2026, at ~$246/share. This is a modest conviction buy from a director, representing ~0.003% of the $15.3B market cap, a trivial dollar amount relative to company size. The buy is notable only for its timing alongside strong analyst consensus (96% bullish), but the absolute dollar value is too small to carry a meaningful signal.
Key Financial Metrics
Key Facts
- Director Jean Jacques Bienaime bought 2,000 shares total for $493K on August 14, 2026
- Purchases were at ~$245.85 and ~$246.91 per share
- Total buy represents ~0.003% of ASND's $15.3B market cap
- Analyst consensus is 96% bullish (25 Buy, 1 Hold, 0 Sell)
- No C-suite insider participated in this buy
Financial Impact
$493K total insider purchase, negligible relative to $15.3B market cap
Risk Factors
- Director buy is trivial relative to market cap, may be a routine portfolio adjustment
- No C-suite participation reduces signal strength
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001610717-26-000360 |
Track record
41 reports on ASND
14 of 19 bullish or bearish reports moved the stock their way by T+60. Best: +26.62% at T+20 after the Jun 2, 2026 report. 25 of 27 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $271.96 Now $271.73 −0.08% settles Feb 12
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $275.39 Now $271.73 −1.33% settles Feb 11
- Nov 12, 20264d ago 6-K Bullish 6/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
- Nov 12, 20264d ago Press Release Neutral 5/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
- Nov 6, 202610d ago 6-K Bullish 6/10 Entry $259.85 Now $271.73 +4.57% settles Feb 5
- Nov 6, 202610d ago Press Release Bullish 6/10 Entry $256.82 Now $271.73 +5.81% settles Feb 4
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $253.45 Now $271.73 +7.21% settles Feb 3
- Nov 2, 202614d ago Institutional Cluster Bullish 4/10 Entry $250.17 Now $271.73 +8.62% settles Feb 1
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $245.85 Now $271.73 +10.53% settles Jan 25
- Oct 16, 20264w ago 6-K Bullish 7/10 Entry $225.25 Now $271.73 +20.63% settles Jan 13
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers